DNA repair pathways in cancer therapy and resistance
L Li, Y Guan, X Chen, J Yang, Y Cheng - Frontiers in pharmacology, 2021 - frontiersin.org
DNA repair pathways are triggered to maintain genetic stability and integrity when
mammalian cells are exposed to endogenous or exogenous DNA-damaging agents. The …
mammalian cells are exposed to endogenous or exogenous DNA-damaging agents. The …
Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology
MA Tempero, MP Malafa, M Al-Hawary… - Journal of the National …, 2021 - jnccn.org
Pancreatic cancer is the fourth leading cause of cancer-related death among men and
women in the United States. A major challenge in treatment remains patients' advanced …
women in the United States. A major challenge in treatment remains patients' advanced …
[HTML][HTML] Curing pancreatic cancer
B Traub, KH Link, M Kornmann - Seminars in cancer biology, 2021 - Elsevier
The distinct biology of pancreatic cancer with aggressive and early invasive tumor cells, a
tumor promoting microenvironment, late diagnosis, and high therapy resistance poses major …
tumor promoting microenvironment, late diagnosis, and high therapy resistance poses major …
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the clinical practice of hereditary colorectal cancer
N Tomita, H Ishida, K Tanakaya, T Yamaguchi… - International Journal of …, 2021 - Springer
Hereditary colorectal cancer (HCRC) accounts for< 5% of all colorectal cancer cases. Some
of the unique characteristics commonly encountered in HCRC cases include early age of …
of the unique characteristics commonly encountered in HCRC cases include early age of …
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international …
EK Bancroft, EC Page, MN Brook, S Thomas… - The Lancet …, 2021 - thelancet.com
Background Lynch syndrome is a rare familial cancer syndrome caused by pathogenic
variants in the mismatch repair genes MLH1, MSH2, MSH6, or PMS2, that cause …
variants in the mismatch repair genes MLH1, MSH2, MSH6, or PMS2, that cause …
Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers
Objective Germline pathogenic variants (PVs) in the DNA mismatch repair (MMR) genes and
in the base excision repair gene MUTYH underlie hereditary colorectal cancer (CRC) and …
in the base excision repair gene MUTYH underlie hereditary colorectal cancer (CRC) and …
Therapeutic strategies targeting tumor suppressor genes in pancreatic cancer
KK Kuo, PJ Hsiao, WT Chang, SC Chuang, YH Yang… - Cancers, 2021 - mdpi.com
Simple Summary Tumor suppressor genes are critical in the control of many biological
functions. They can be classified based on their roles in proliferation, cell-cycle progression …
functions. They can be classified based on their roles in proliferation, cell-cycle progression …
[HTML][HTML] Germline and tumor sequencing as a diagnostic tool to resolve suspected Lynch syndrome
Patients in whom mismatch repair (MMR)-deficient cancer develops in the absence of
pathogenic variants of germline MMR genes or somatic hypermethylation of the MLH1 gene …
pathogenic variants of germline MMR genes or somatic hypermethylation of the MLH1 gene …
Clinical contribution of next-generation sequencing multigene panel testing for BRCA negative high-risk patients with breast cancer
Background Breast cancer is the most common malignancy in women and thought to be
hereditary in 10% of patients. Recent next-generation sequencing studies have increased …
hereditary in 10% of patients. Recent next-generation sequencing studies have increased …
Stakeholders' views of integrating universal tumour screening and genetic testing for colorectal and endometrial cancer into routine oncology
R O'Shea, NM Rankin, M Kentwell, M Gleeson… - European Journal of …, 2021 - nature.com
Mainstream genetic testing in routine oncology care requires implementation research to
inform intervention design. In Australia, funding is available for oncology health …
inform intervention design. In Australia, funding is available for oncology health …